Diagnostics & Research
The Diagnostics & Research industry has a total of 47 stocks, with a combined market cap of $676.48 billion, total revenue of $165.59 billion and a weighted average PE ratio of 38.47.
Market Cap
676.48B
Revenue
165.59B
Profits
17.58B
PE Ratio
38.47
Profit Margin
10.62%
Dividend Yield
0.24%
47 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 191.76B | -2.95% | 1,375,322 | 44.56B |
| 2 | DHR | Danaher Corporation | 137.14B | -2.20% | 3,760,486 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 45.27B | -1.86% | 337,655 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 33.42B | -1.27% | 1,697,848 | 7.07B |
| 5 | WAT | Waters Corporation | 31.32B | -2.19% | 733,531 | 3.17B |
| 6 | IQV | IQVIA Holdings Inc. | 28.86B | -3.45% | 1,536,819 | 16.31B |
| 7 | NTRA | Natera, Inc. | 27.79B | -5.35% | 1,849,024 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 26.14B | -1.90% | 168,632 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 21.89B | -0.14% | 592,840 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.19B | 0.02% | 987,367 | 11.04B |
| 11 | ILMN | Illumina, Inc. | 20.16B | 0.35% | 1,325,563 | 4.34B |
| 12 | MEDP | Medpace Holdings, Inc. | 14.73B | -0.56% | 345,112 | 2.53B |
| 13 | GH | Guardant Health, Inc. | 11.24B | 0.99% | 1,984,246 | 982.02M |
| 14 | RVTY | Revvity, Inc. | 10.01B | -3.63% | 1,192,219 | 2.86B |
| 15 | ICLR | ICON Public Limited Company | 8.83B | -0.79% | 1,139,196 | 8.10B |
| 16 | CRL | Charles River Laboratories International, Inc. | 8.73B | -2.00% | 915,067 | 4.02B |
| 17 | QGEN | Qiagen N.V. | 8.47B | -1.63% | 1,291,255 | 2.09B |
| 18 | RDNT | RadNet, Inc. | 4.66B | 3.21% | 2,249,998 | 2.04B |
| 19 | SHC | Sotera Health Company | 4.51B | -1.25% | 2,710,831 | 1.16B |
| 20 | BLLN | BillionToOne, Inc. | 3.62B | -2.22% | 298,834 | 305.11M |
| 21 | TWST | Twist Bioscience Corporation | 3.45B | -2.41% | 1,426,923 | 391.56M |
| 22 | VCYT | Veracyte, Inc. | 2.62B | -2.97% | 588,206 | 517.15M |
| 23 | GRAL | GRAIL, Inc. | 2.03B | -0.64% | 520,752 | 147.17M |
| 24 | WGS | GeneDx Holdings Corp. | 1.92B | -3.02% | 366,410 | 427.54M |
| 25 | CDNA | CareDx, Inc. | 1.15B | 27.60% | 2,964,544 | 379.81M |
| 26 | NEO | NeoGenomics, Inc. | 1.06B | -5.99% | 1,719,370 | 727.33M |
| 27 | OPK | OPKO Health, Inc. | 918.47M | 2.54% | 4,433,902 | 606.88M |
| 28 | CSTL | Castle Biosciences, Inc. | 744.07M | -0.24% | 261,814 | 344.23M |
| 29 | PSNL | Personalis, Inc. | 697.15M | 0.45% | 879,816 | 69.65M |
| 30 | MYGN | Myriad Genetics, Inc. | 467.54M | -3.66% | 1,359,616 | 824.50M |
| 31 | FLGT | Fulgent Genetics, Inc. | 465.26M | -0.25% | 425,690 | 322.67M |
| 32 | PRE | Prenetics Global Limited | 301.90M | 1.07% | 104,035 | 92.39M |
| 33 | BNR | Burning Rock Biotech Limited | 242.25M | 9.44% | 35,950 | 77.14M |
| 34 | BDSX | Biodesix, Inc. | 134.53M | 5.13% | 50,990 | 88.50M |
| 35 | FONR | FONAR Corporation | 122.98M | -0.05% | 19,564 | 106.03M |
| 36 | MDXH | MDxHealth SA | 113.00M | -4.76% | 130,253 | 107.88M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 112.91M | 2.63% | 484,350 | 4.06M |
| 38 | XGN | Exagen Inc. | 73.36M | -0.65% | 159,131 | 66.58M |
| 39 | PRPO | Precipio, Inc. | 51.73M | -1.66% | 8,141 | 24.05M |
| 40 | MBAI | Check-Cap Ltd. | 13.56M | 7.51% | 172,144 | - |
| 41 | BIAF | bioAffinity Technologies, Inc. | 12.40M | -5.80% | 233,127 | 6.16M |
| 42 | NOTV | Inotiv, Inc. | 10.15M | -24.26% | 2,901,575 | 514.03M |
| 43 | XWEL | XWELL, Inc. | 8.24M | -5.45% | 204,024 | 29.21M |
| 44 | ADVB | Advanced Biomed Inc. | 6.51M | -23.06% | 33,744 | - |
| 45 | NDRA | ENDRA Life Sciences Inc. | 6.41M | 0.58% | 7,449 | - |
| 46 | QUCY | Mainz Biomed N.V. | 6.31M | -7.70% | 1,105,997 | 537.08K |
| 47 | ISPC | iSpecimen Inc. | 3.46M | 4.20% | 51,840,906 | 1.93M |